Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omsynth Lifesciences is an India-based contract research and manufacturing organization (CRMO) that specializes in the development and production of high-quality active pharmaceutical ingredients (APIs) and advanced intermediates. The company provides a wide range of services, including custom synthesis, process research and development, and commercial-scale manufacturing for the global pharmaceutical and biotech industries. With a core expertise in complex organic chemistry, Omsynth supports its clients through various stages of drug discovery and development. Their state-of-the-art facilities are equipped to handle multi-step synthesis and scale-up processes, ensuring cost-effective and timely delivery of chemical entities. Omsynth also offers specialized services in impurity profiling and the synthesis of reference standards to support regulatory filings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omsynth Lifesciences.